Inhibitor development according to FVIII concentrates in previously untreated patients with severe hemophilia A: update from the PedNet registry.

Saved in:
Bibliographic Details
Title: Inhibitor development according to FVIII concentrates in previously untreated patients with severe hemophilia A: update from the PedNet registry.
Authors: Fischer K; Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands; PedNet Research Foundation, Baarn, Netherlands., Olivieri M; Paediatric Thrombosis and Haemostasis Unit, Paediatric Haemophilia Center, Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany., Ranta S; Pediatric Coagulation Unit, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Pediatric Oncology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Pinto F; Department of Haematology, Royal Hospital for Sick Children, Yorkhill, Glasgow, UK., Labarque V; University Hospitals Leuven, Service of Pediatric Haematology, Leuven, Belgium; KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium., Zapotocka E; Department of Pediatric Hematology and Oncology, University Hospital Motol and Homolka and Second Faculty of Medicine, Charles University, Prague, Czech Republic., Motwani J; Department of Haematology, Children's Hospital, Birmingham, UK., Kenet G; PedNet Research Foundation, Baarn, Netherlands; National Hemophilia Center, Sheba Medical Center, Tel Hashomer and Amalia Biron Research Institute of Thrombosis and Hemostasis, Tel Aviv University, Israel., Königs C; Goethe University, University Hospital Frankfurt, Department of Paediatrics and Adolescent Medicine, Frankfurt, Germany., Nolan B; Department of Paediatric Haematology, Children's Coagulation Centre, Children's Health Ireland at Crumlin, Dublin, Ireland., Blatný J; HCCC, Centre for Thrombosis and Haemothasis at the Department of Paediatric Haematology and Biochemistry, University Hospital Brno, Brno, Czech Republic., Carcao M; Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children, Toronto, Canada., Van Geet C; University Hospitals Leuven, Service of Pediatric Haematology, Leuven, Belgium; KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium., de Kovel M; PedNet Research Foundation, Baarn, Netherlands. Electronic address: m.s.dekovel@pednet.eu., Andersson NG; Department of Clinical Sciences, Lund University, Lund, Sweden; Department of Pediatrics and Malmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden.
Corporate Authors: PedNet Study Group
Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2026 May 12. Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first